Activated CD8 + T cells differentiate into cytotoxic effector (T EFF ) cells that eliminate target cells. How T EFF cell identity is established and maintained is not fully understood. We found that Runx3 deficiency limited clonal expansion and impaired upregulation of cytotoxic molecules in T EFF cells. Runx3-deficient CD8 + T EFF cells aberrantly upregulated genes characteristic of follicular helper T (T FH ) cell lineage, including Bcl6, Tcf7 and Cxcr5. Mechanistically, the Runx3-CBF transcription factor complex deployed H3K27me3 to Bcl6 and Tcf7 genes to suppress the T FH program. Ablating Tcf7 in Runx3-deficient CD8 + T EFF cells prevented the upregulation of T FH genes and ameliorated their defective induction of cytotoxic genes. As such, Runx3mediated Tcf7 repression coordinately enforced acquisition of cytotoxic functions and protected the cytotoxic lineage integrity by preventing T FH -lineage deviation.
Transcription factors have central roles in establishing and maintaining cell identity during development, homeostasis and response to environmental changes 1 . In the immune system, CD4 + and CD8 + T cells are functionally distinct helper and cytotoxic lineages whose identity is stipulated by distinct transcription factors [2] [3] [4] . The transcription factor ThPOK is essential for the CD4 + T lineage choice during development and for maintaining CD4 + T lineage integrity, largely by restraining activation of Runx-CBF-complex-dependent transcriptional programs 5, 6 . Two other transcription factors, Tcf1 and Lef1, although not required for CD8 + T lineage decision, have critical roles in establishing CD8 + T cell identity through their intrinsic histone deacetylase (HDAC) activity 7, 8 . In response to acute infection by intracellular microbes, CD8 + T cells differentiate into dedicated cytotoxic effector cells that eliminate infected target cells [9] [10] [11] , whereas CD4 + T cells give rise to T helper 1 (T H 1), T H 2, T H 17 and follicular helper T (T FH ) cells depending on the nature of pathogens 12, 13 .
Maintaining the identity of CD8 + effector T (T EFF ) cells elicited by acute infections is essential for their cytotoxic capacity. The best-known transcriptional regulators in this regard include T-bet, Eomes and Blimp-1, which are potently induced following CD8 + T cell activation 14 . Deletion of either T-bet or Eomes alone does not have a pronounced effect, whereas combined deletion of both factors causes aberrant activation of the T H 17 program, including upregulation of Rorγt, along with interleukins 17A (IL-17A) and 21 (IL-21) 15 . Compound deletion of T-bet and Blimp-1 leads to induction of Rorγt and IL-17A in CD8 + T EFF cells 16 . These IL-17-producing, T-bet-Eomes-or T-bet-Blimp-1-deficient CD8 + T EFF cells cause progressive inflammatory and wasting syndrome, highlighting an essential requirement for maintaining the cytotoxic lineage integrity. However, it remains unknown whether other T helper subset plasticity is transcriptionally and/or epigenetically suppressed in CD8 + T EFF cells.
The Runx-CBF complex consists of unique DNA-binding α subunits (Runx1, 2 or 3) and the obligatory cofactor CBFβ, which does not bind DNA, but instead stabilizes the Runx-DNA interaction 17, 18 . Runx1 and Runx3 are predominantly expressed in T lineage cells and have redundant functions in repressing ThPOK expression to ensure generation of CD8 + T cells and Cd4 gene silencing in CD8 + T cells during thymic development 19, 20 . A role of Runx3 in inducing interferon-γ (IFN-γ), perforin and granzyme B expression in activated mature CD8 + T cells has been suggested by studies using germline-targeted Runx3-deficient CD8 + T cells responding to in vitro stimulation 21, 22 . However, the in vivo function of the Runx-CBF complex during CD8 + T cell responses remains unknown. By specifically targeting Runx3 in mature T cells and using in vivo infection models, we uncovered an essential role of Runx3 in guarding CD8 + T EFF cells from deviation to the T FH cell lineage, as well as inducing the expression of cytotoxic mediators. 9 3 2 VOLUME 18 NUMBER 8 AUGUST 2017 nature immunology A r t i c l e s
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Loss of Runx3 impairs CD8 + T EFF cell expansion and function
To address the role of Runx3 in CD8 + T cell responses in a physiological setting of in vivo infection, we generated hCD2-Cre + Rosa26 GFP Runx3 FL/FL (Runx3 −/− hereafter) mice in which hCD2-Cre specifically deleted loxP-flanked genes in mature T cells 6, 23 . Thymic development was similar between Runx3 −/− mice and Runx3 +/+ or Runx3 +/− littermate controls (referred to as wild-type because CD8 + T cells in these genotypes behaved similarly in all assays; Supplementary Fig. 1a ). hCD2-Cre-mediated deletion did not occur in natural killer cells, but was efficient in CD8 + T cells, as indicated by GFP expression (Supplementary Fig. 1b) . Deletion of Runx3 protein in Runx3 −/− CD8 + T cells was confirmed by intracellular staining (Supplementary  Fig. 1c ). The number of CD8 + T cells in the spleen of Runx3 −/− mice was reduced by about 40% compared with wild-type mice, but these cells did not exhibit derepression of CD4 co-receptor or an aberrant activation phenotype (Supplementary Fig. 1d,e ). On day 8 post-infection (8 dpi) with the Armstrong strain of lymphocytic choriomeningitis virus (LCMV-Arm), Runx3 −/− mice showed diminished frequency and numbers of LCMV glycoprotein 33-41 (GP33)specific CD8 + T EFF cells compared with wild-type mice, as detected by GP33-tetramer or GP33-peptide-stimulated IFN-γ production ( Fig. 1a) . In contrast with effective clearance of the virus in wildtype mice on 8 dpi, high titers of LCMV were detected in the livers, spleens and lungs of Runx3 −/− mice (Fig. 1b) . These data suggest an essential requirement for Runx3 in mounting protective CD8 + T cell responses.
We also generated hCD2-Cre + Rosa26 GFP Cbfb fl/fl (Cbfb −/− hereafter) mice, in which CBFβ is ablated in peripheral CD8 + T cells ( Supplementary Fig. 2a ). The number of CD8 + T EFF cells was greatly diminished in Cbfb −/− mice in response to LCMV-Arm infection compared with Cbfb +/+ or Cbfb +/− littermate controls, similar to Runx3 −/− mice ( Supplementary Fig. 2b ), suggesting that the Runx3-CBFβ complex has a predominant role in CD8 + T cell responses to acute infections, without a strong contribution from the Runx1-CBFβ complex. In addition, in a bacterial infection model using Listeria monocytogenes expressing ovalbumin 257-264 (OVA257) and GP33 epitopes (LM-OVA-GP33), we found a greater than four-fold reduction in the numbers of OVA-and GP33-specific CD8 + T EFF cells in Runx3 −/− mice compared with wild-type mice ( Supplementary  Fig. 2c-e ), indicating a requirement for Runx3 in CD8 + T cell responses independent of infection type or epitope.
To control for potential alterations in precursor frequency, we crossed Runx3 −/− with an MHC-I-restricted P14 transgenic T cell receptor (TCR) that is specific for the LCMV-GP33 epitope. We adoptively transferred 2 × 10 4 naive Runx3 −/− or wild-type (Runx3 +/+ or Runx3 +/− ) P14 CD8 + T cells into congenic recipients, followed by infection with LCMV-Arm. Runx3 −/− P14 CD8 + T EFF cells showed substantially lower clonal expansion than wild-type cells from 5-8 dpi in the blood and spleen of infected recipient mice ( Fig. 1c) . Functionally, Runx3 −/− P14 CD8 + T EFF cells produced less IFN-γ, tumor necrosis factor (TNF) and IL-2, and showed reduced expression of granzyme B compared with wild-type cells ( Fig. 1d) . Runx3 −/− and wild-type P14 CD8 + T EFF cells had a similar capacity to upregulate T-bet and Eomes ( Fig. 1e) , in contrast with findings from a previous study, which reported impaired induction of Eomes in Runx3-deficient CD8 + T cells activated in vitro 21 .
These data indicate an intrinsic requirement for Runx3 in the clonal expansion and the acquisition of cytotoxic functions in CD8 + T EFF cells.
Runx3 activates the cytotoxic program in CD8 + T EFF cells
We detected more active caspase3 and caspase7 in Runx3 −/− P14 CD8 + T EFF cells than wild-type cells on 6 and 8 dpi ( Supplementary  Fig. 3a) , indicating that Runx3-deficient CD8 + T EFF cells are more prone to apoptosis, whereas this effect was less pronounced on 4 dpi. To assess the early effect of Runx3 deficiency on CD8 + T EFF cells while avoiding the inclusion of a high portion of apoptotic cells, we sort-purified CD45.2 + Runx3 −/− P14 or wild-type P14 CD8 + T EFF cells on 4 dpi from CD45.1 + recipient spleens and performed RNA-Seq. Using the Cuffdiff algorithm at a setting of greater than two-fold expression changes and false discovery rate (FDR) ≤0.01, we found that 422 genes were upregulated and 231 genes were downregulated in Runx3 −/− P14 CD8 + T EFF cells compared with wild-type cells ( Fig. 2a,b) , some of which (13.2% for down-and 11.4% for upregulated genes) were previously identified in Runx3-deficient CD8 + T cells activated in vitro 22 (Supplementary Fig. 3b,c) .
Among the downregulated genes, Prdm1, which encodes the transcription factor Blimp-1, a critical regulator of CD8 + T EFF cell 
Tcf7 lcos A r t i c l e s differentiation 24, 25 , showed reduced expression in Runx3 −/− P14 CD8 + T EFF cells ( Fig. 2a,b) , as did genes encoding cytotoxic effector molecules, such as Gzma, Gzmb, Prf1 and Fasl, as validated by quantitative reverse transcription PCR (RT-PCR; Fig. 2c ) or flow cytometry ( Fig. 1d ). In terms of upregulated genes, Runx3 −/− P14 CD8 + T EFF cells showed increased expression of Bcl2l11, which encodes the pro-apoptotic Bim protein, and many genes associated with the T FH lineage cells, including Bcl6, Maf and Tcf7 (encoding Bcl-6, Maf and Tcf1 transcription factors, respectively), Icos, Il6ra and Il6st (encoding ICOS, IL-6Rα and gp130 signaling receptors, respectively), Cxcr5 and Il21 (ref. 13) ( Fig. 2a,b) . These data indicate that Runx3 controls a broad transcriptional program that includes activation of the cytotoxic machinery in CD8 + T EFF cells.
Runx3 suppresses the T FH program in CD8 + T EFF cells
We next investigated the functional relevance of the induced T FHlineage-associated genes in Runx3 −/− CD8 + T EFF cells during acute viral infection. Over 4-8 d after LCMV-Arm infection, which followed adoptive transfer of P14 CD8 + T cells, >35% Runx3 −/− P14 CD8 + T EFF cells in the spleens were CXCR5 + , and these Runx3 −/− P14 CXCR5 + CD8 + T cells were SLAM lo Tcf1 hi Bcl-6 + , whereas only a few wild-type P14 CD8 + T EFF cells showed weak CXCR5 expression ( Fig. 3a) . Runx3 −/− P14 CD8 + T EFF cells generated in response to infection by LM-GP33 also contained a CXCR5 + subset ( Supplementary  Fig. 4a ). A T FH -enriched gene set, which contains genes that are expressed ≥2-fold higher in wild-type CD4 + T FH cells than in T H 1 cells elicited by LCMV-Arm infection has been defined 23 . Gene set 
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Runx3 with ELISA on day 7 post-immunization after CD45.1 + Bcl6 −/− recipient mice were either not transferred or adoptively transferred with 1 × 10 5 sortpurified naive CD45.2 + WT or Runx3 −/− P14 CD8 + T cells and then immunized with KLH-GP33. KLH-specific IgG was also detected in another cohort of CD45.1 + Bcl6 −/− mice that were transferred with 1 × 10 5 naive WT SMARTA CD4 + T cells and then immunized with KLH-GP61. The relative titers at 1:50 dilution, after normalizing to the average of WT P14 T cell recipient replicates, were pooled from 2-3 independent experiments. Statistical significance for the multi-group comparisons was determined using both unpaired t test and post hoc tests, yielding similar outcomes. ns, not statistically significant; *P < 0.05 (Bonferroni's test).
A r t i c l e s enrichment analysis (GSEA) revealed a broad upregulation of T FHenriched genes in Runx3 −/− CD8 + T EFF cells compared with wild-type cells ( Fig. 3b and Supplementary Fig. 4b ).
CXCR5 expression guides CD4 + T FH cells into the B cell follicles. Among CD45.2 + CD8 + T EFF cells elicited by LCMV-Arm infection following adoptive transfer, <1% of wild-type P14 CD8 + T EFF cells were detected in the B cell follicles of recipient spleens. In contrast, approximately 10% of Runx3 −/− P14 CD8 + T EFF cells localized in the B cell follicles, in spite of their greatly reduced numbers ( Fig. 3c) . P14 CD8 + T cells activated by LCMV clone 13 (LCMV-Cl13), which causes chronic infection in mice, became exhausted. Consistent with recent studies [26] [27] [28] , about 20% of wild-type exhausted P14 CD8 + T cells were CXCR5 + and were detected in the B cell follicles; by comparison, Runx3 −/− exhausted P14 CD8 + T cells showed a 2-3-fold increase in the CXCR5 + subset and follicle localization ( Supplementary  Fig. 4c,d) . These data indicate that Runx3 suppresses the induction of a T FH cell transcriptional program in CD8 + T cells in response to diverse activation signals.
Runx3 −/− CXCR5 + CD8 + T cells acquire B cell helper function
To test whether Runx3 −/− CXCR5 + CD8 + T cells have T FH -like B cell helper functions, we adoptively transferred P14 CD8 + T cells into wild-type congenic mice and immunized recipient mice with GP33 peptide conjugated with keyhole limpet hemocyanin (KLH-GP33) in the rear footpads. On day 7 post-immunization, both Runx3 −/− and wild-type P14 CD8 + T cells were activated (Fig. 4a) , and the resulting Runx3 −/− P14 CD8 + T EFF cells were diminished in number compared with wild-type cells in the draining inguinal lymph node (LN) (Fig. 4b) .
Whereas about 25% of wild-type P14 CD8 + T EFF cells in the inguinal LNs elicited by protein immunization were CXCR5 + , >70% of Runx3 −/− P14 CD8 + T EFF cells exhibited a CXCR5 + SLAM lo phenotype ( Fig. 4b) . Compared with wild-type P14 CXCR5 + CD8 + T EFF cells, Runx3 −/− P14 CXCR5 + CD8 + T EFF cells had higher expression of ICOS and Bcl-6, as well as CD40L, which directly mediates T-B cell interaction (Fig. 4b) . In addition, Runx3 −/− P14 CD8 + T EFF cells were about three-fold more frequently detected in the B cell follicles in inguinal LNs than wild-type P14 CD8 + T EFF cells (Fig. 4c) .
To specifically address whether Runx3 −/− CXCR5 + CD8 + T EFF cells can provide B cell help, we sort-purified CD45.2 + naive wild-type or Runx3 −/− P14 CD8 + T cells to eliminate contaminating CD4 + T cells and adoptively transferred them into CD45.1 + CD4-Cre + Bcl6 fl/ fl (hereafter Bcl6 −/− ) mice, in which the endogenous T FH response is abrogated, but B cells are functional, and then immunized the mice with KLH-GP33. On day 7 post-immunization, serum KLH-specific A r t i c l e s IgG titers were not significantly different in Bcl6 −/− mice that were not transferred or were transferred with wild-type P14 CD8 + T cells (Fig. 4d) . On the other hand, Bcl6 −/− mice that received Runx3 −/− P14 CD8 + T cells showed elevated titers of KLH-specific IgG on days 7 and 21 post-immunization ( Fig. 4d and Supplementary  Fig. 4e ), suggesting that Runx3 −/− CXCR5 + CD8 + effectors can function as B cell helpers. Of note, Bcl6 −/− mice transferred with Runx3 −/− P14 cells did not develop germinal centers (data not shown), indicating that KLH-specific IgG production in these mice was not dependent on germinal centers [29] [30] [31] . As a control, we adoptively transferred wild-type SMARTA CD4 + T cells, which express an MHC-II-restricted TCR specific for LCMV GP61 epitope, into Bcl6 −/− recipients and immunized the mice with GP61-conjugated KLH, leading to the induction of higher titers of KLH-specific IgG in recipient mice than in Bcl6 −/− mice transferred with Runx3 −/− P14 CD8 + T cells (Fig. 4d) . To directly compare the expression of key T FH molecules in Runx3 −/− CD8 + T cells and wild-type CD4 + T FH cells, we co-transferred Runx3 −/− P14 CD8 + T cells and wild-type SMARTA CD4 + T cells into Bcl6 −/− recipients, and then immunized them with both KLH-GP33 and KLH-GP61. On day 7 post-immunization, wildtype CD4 + T FH cells showed similar ICOS and CD40L expression as Runx3 −/− CXCR5 + CD8 + T EFF cells, but expressed higher CXCR5, Bcl-6 and Tcf1 proteins than the latter (Supplementary Fig. 4f) , which possibly explains the more efficient B cell help by wild-type CD4 + T FH cells. Together, these results indicate that the loss of Runx3 expression confers T FH -like functions to CD8 + T EFF cells.
Runx3 deploys H3K27me3 to key T FH gene loci
To define the mechanisms by which the Runx-CBFβ complex coordinates the repression of the T FH program and activation of the cytotoxic program in CD8 + T EFF cells in response to acute infection, we performed CBFβ ChIP-Seq using a CBFβ antiserum 32 in wild-type KLRG1 hi IL-7Rα lo P14 CD8 + T EFF cells sort-purified on day 8 after LCMV-Arm infection. Cbfb −/− naive CD8 + T cells were used as a negative control. Using MACS algorithm with stringent settings (≥4-fold enrichment over the negative control, P < 1 × 10 −5 and FDR<0.05), we identified 12,981 high-confidence CBFβ-binding peaks in CD8 + T EFF cells. Approximately 40% CBFβ peaks were detected in gene promoters, whereas 23% and 37% were distributed in the gene body and intergenic regions, respectively (Supplementary Fig. 5a ). The CBFβ peaks partly overlapped with Runx3-binding peaks that were previously identified by Runx3 ChIP-Seq in CD8 + T cells activated in vitro 22 , and de novo motif discovery analysis identified a highly enriched Runx-binding motif in the CBFβ peaks in both promoters and enhancer-overlapping regions (Supplementary Fig. 5b,c) .
To define how the Runx-CBFβ complex co-opts epigenetic mechanisms for target gene regulation, we performed ChIP-Seq of H3K4me1, H3K4me3, H3K27me3 and H3K27ac histone marks on wild-type and Runx3 −/− P14 CD8 + T EFF cells that were sort-purified on day 4 after LCMV-Arm infection. We first mapped the direct association of CBFβ peaks with the Runx-CBF-repressed gene loci, that is, genes upregulated in Runx3 −/− over wild-type P14 CD8 + T EFF cells (Supplementary Table 1 ). The CBFβ peaks within the −5 kb to transcription end site (TES) regions were associated with strong H3K27me3 signals in wild-type P14 CD8 + T EFF cells, whereas the H3K27me3 marks at the same genomic locations were greatly diminished in Runx3 −/− P14 CD8 + T EFF cells ( Supplementary  Fig. 5d ). In contrast, CBFβ peaks outside these regions were not marked with strong H3K27me3 in wild-type P14 CD8 + T EFF cells, and the H3K27me3 marks were largely unaffected in Runx3 −/− P14 CD8 + T EFF cells. On the other hand, H3K4me3 signals at the CBFβ peaks were similar between wild-type and Runx3 −/− P14 CD8 + T EFF cells (Supplementary Fig. 5d ).
We further partitioned CBFβ peaks based on their association with the promoter regions, defined as −1 kb to +1 kb flanking the transcript start sites (TSS). Promoter-associated CBFβ peaks had strong signals of both H3K27me3 and H3K4me3 in wild-type P14 CD8 + T EFF cells (Fig. 5a) , indicating a bivalent state. In contrast, these CBFβ peaks showed a substantial decrease in H3K27me3, but retained H3K4me3 in Runx3 −/− P14 CD8 + T EFF cells (Fig. 5a) , suggesting that the poised, bivalent promoters may become actively transcribed without Runx3-mediated repression. Among the 422 Runx3-CBF-repressed genes, 219 promoters showed bivalency in wild-type P14 CD8 + T EFF cells. 48 of these bivalent promoters were marked solely with H3K4me3 in Runx3 −/− P14 CD8 + T EFF cells, including Bcl2l11 and key T FH genes such as Bcl6 and Tcf7 (Fig. 5b,c and Supplementary Fig. 5e ). CBFβ did not bind to Bcl6 TSS, but showed modest enriched binding at a −37-kb regulatory region upstream of Tcf7 in naive CD8 + T cells; on the other hand, CBFβ bound strongly to both regions in wild-type P14 CD8 + T EFF cells (Fig. 5b,c) . This observation suggests that Runx3-CBFβ can be pre-positioned at critical regulatory regions before antigen encounter; it then further stabilizes binding to these regions or acquires access to new regulatory elements during CD8 + T EFF cell differentiation. Our data indicate that Runx3-CBFβ deploys the H3K27me3 mark to repress its target genes, either through promoters or distal regulatory regions.
Runx3 activates promoters and enhancers of cytotoxic genes Runx3 binds to key cytotoxic genes, such as Prf1 and Gzmb 21, 22 . To validate and expand on the regulatory roles of the Runx-CBFβ complex in activating the cytotoxic program, we focused on the 231 Runx-CBF-activated gene loci, that is, genes downregulated in Runx3 −/− over wild-type P14 CD8 + T EFF cells. The CBFβ ChIP-Seq peaks were found in 39 gene promoters in wild-type P14 CD8 + T EFF cells, including Prf1, Gzmb and Prdm1 ( Fig. 6 and Supplementary Table 1 ).
Using the H3K4me1 hi H3K4me3 neg/lo H3K27ac hi H3K27me3 neg/lo histone modification signature 33 , we mapped active enhancers in wildtype and Runx3 −/− P14 CD8 + T EFF cells. Of the 321 CBFβ peaks found within 50 kb of the Runx-CBF-activated gene loci (but outside promoters) in wild-type P14 CD8 + T EFF cells, 72 were associated with 57 active enhancers, which were distributed in 35 genes, including Gzmb, Ifng, Fasl and Gzma (Fig. 6c, Supplementary Fig. 6a-c and Supplementary  Table 1 ). Clustering analysis revealed that 43 active enhancers in wildtype P14 CD8 + T EFF cells, including those in Gzmb and Ifng, remained active in Runx3 −/− P14 CD8 + T EFF cells (Supplementary Fig. 6d ), whereas 14 active enhancers, including those in Fasl and Gzma, lost H3K27ac and/or gained H3K27me3 in Runx3 −/− P14 CD8 + T EFF cells (Supplementary Fig. 6d ), indicating that they became inactive. These analyses suggest that Runx3 not only acts through pre-formed enhancers, but also contributes to enhancer activation in select target genes. We detected enriched binding of the Runx3-CBFβ complex in the TSS of Prf1, Gzmb and Prdm1 genes using ChIP-qPCR, as well as in a −22 kb enhancer upstream of Gzmb in wild-type P14 CD8 + T EFF cells (Fig. 6a-c) . In naive CD8 + T cells, however, CBFβ did not bind to the Gzmb TSS or −22 kb enhancer or Prdm1 TSS, and only showed modest enrichment at the Prf1 TSS ( Fig. 6a-c) . These data indicate that the Runx3-CBFβ complex can be pre-positioned at the promoters of Runx-CBF-activated genes in naive CD8 + T cells and then further stabilize binding, or can acquire access to new promoters or active enhancers during CD8 + T EFF cell differentiation.
Runx3 suppresses Tcf1 to repress the T FH program in T EFF cells
To further define the mechanism by which Runx3 represses the T FH program in CD8 + T EFF cells, we focused on Tcf1, which is critical for inducing Bcl-6 and repressing Blimp-1 in CD4 + T FH cells 23, 34, 35 . We adoptively transferred P14 CD8 + T cells from A r t i c l e s (Runx3 −/− Tcf7 −/− ) and control (with genotype of Runx3 +/+ Tcf7 +/+ , Runx3 +/− Tcf7 +/+ , Runx3 +/+ Tcf7 +/− or Runx3 +/− Tcf7 +/− , referred to as wild-type because CD8 + T cells in these genotypes behaved similarly in all assays) P14 TCR transgenic mice into congenic recipient mice, followed by infection with LCMV-Arm. On 6 dpi, unlike wild-type or Tcf7 −/− P14 CD8 + T EFF cells, only Runx3 −/− P14 CD8 + T EFF cells contained a distinct CXCR5 + SLAM lo ICOS hi subset, which was completely abrogated in Runx3 −/− Tcf7 −/− P14 CD8 + T EFF cells (Fig. 7a) .
In addition, the increase in Bcl6 and Il21 transcripts in Runx3 −/− P14 CD8 + T EFF cells was abolished in Runx3 −/− Tcf7 −/− cells (Fig. 7b) , suggesting that Tcf1 is responsible for inducing the T FH program in CD8 + T EFF cells. Furthermore, the induction of CXCR5 + SLAM lo ICOS hi CD8 + T EFF cells was abrogated when Runx3 −/− Tcf7 −/− P14 CD8 + T cells were activated by LM-GP33, LCMV Cl13 or GP33-KLH immunization (Supplementary Figs. 4a,c and 7a) , indicating that Runx3-mediated repression of Tcf1 is a conserved molecular circuit that prevents activation of the T FH program in CD8 + T EFF cells that are activated by diverse stimuli.
Compared with Runx3 −/− P14 CD8 + T EFF cells, Runx3 −/− Tcf7 −/− P14 CD8 + T EFF cells showed an about four-fold increase in clonal expansion on day 6 after LCMV-Arm infection, albeit still lower than that of wild-type P14 CD8 + T EFF cells (Fig. 7c) . In addition, the decreased CD25 expression, IFN-γ and granzyme B production observed in Runx3 −/− P14 CD8 + T EFF cells was restored in Runx3 −/− Tcf7 −/− cells to a level close to that in wild-type P14 CD8 + T EFF cells (Fig. 7d) . Furthermore, expression of Prdm1, Fasl and Prf1 was higher in Tcf7 −/− Runx3 −/− P14 CD8 + T EFF cells than in Runx3 −/− cells (Fig. 7b) , indicating that repression of Tcf1 by Runx3 is intrinsically necessary for Runx3 to fully activate the cytotoxic program and promote clonal expansion of CD8 + T EFF cells. Collectively, our data suggest that Runx3-CBFβ constitutes a key module of the transcriptional network that allows activated CD8 + T cells to fully acquire cytotoxic functions and prevents deviation to helper lineages in response to acute infections (Supplementary Fig. 7b ).
DISCUSSION
Using in vivo infection models, we found that Runx3 has a dual function during CD8 + T cell responses: activation of the cytotoxic program and repression of the T FH program. Differentiation of CD8 + T EFF cells is orchestrated by multiple transcriptional and epigenetic regulators 14 . In a previous study mapping transcription factor motifs in active enhancers during CD8 + T cell responses, a Runx motif is among the most enriched during the transition of naive to CD8 + T EFF cells 36 .
Unlike T-bet, Eomes or Blimp-1, which are strongly upregulated during CD8 + T EFF cell differentiation, Runx3 is only minimally induced in CD8 + T EFF cells compared with naive CD8 + T cells 36, 37 . As such, Runx3 appears to be a 'housekeeping' factor that acquires regulatory roles in CD8 + T EFF cells by gaining access to new regulatory elements (compared with naive CD8 + T cells) and/or cooperates with newly induced factors to achieve stabilized binding to key targets in the cytotoxic program. Although it is critical for optimal upregulation of Blimp-1 in CD8 + T EFF cells, Runx3 does not appear to be required for induction of T-bet or Eomes. Whether Runx3 and the T-bet-Eomes pathways act in parallel and/or cooperatively to program CD8 + T EFF cell differentiation merits further investigation.
Maintaining the identity of activated CD8 + T cells is critical for their dedicated cytotoxic functions 4 , as indicated by the combined deficiency of T-bet together with Eomes or Blimp-1, a situation in which CD8 + T EFF cells aberrantly produce IL-17 and cause wasting inflammatory diseases 15, 16 . Our observations indicate that Runx3 is required for preventing activation of the T FH program in CD8 + T EFF cells in response to acute infections. By deploying the H3K27me3 repressive mark to T FH -cell-associated gene loci, Runx3 thereby provides constant supervision of CD8 + T EFF cell identity. Because epigenetic spreading of repressive histone marks may differ in individual cells in a population, only a portion of the Runx3-deficient CD8 + T EFF cells showed strong upregulation of CXCR5 and Bcl-6. Of note, key gene loci in the T FH lineage, such as Tcf7 and Bcl6, were in a bivalent state, decorated with both active and repressive histone marks, in wild-type CD8 + T EFF cells. This observation suggests that these genes are in a poised status for potential activation, and thus some T cell lineage plasticity is embedded in CD8 + T EFF cells. In fact, CD8 + T cells have the capacity to produce IL-4 or IL-9 under in vitro polarization conditions, at specific anatomical locations, or under specific allergic or inflammatory conditions in vivo 38 . Thus, beyond activation of the cytotoxic program, Runx3 might cooperate with other key factors, such as T-bet, Eomes and Blimp-1, to prevent the activation of alternative helper programs in the context of acute infections.
Our results indicate that the loss of Tcf1 repression mediates activation of the T FH program in Runx3-deficient CD8 + T EFF cells, and this is consistent with the known role of Tcf1 in promoting CD4 + T FH cell differentiation 23, 34, 35 . On the other hand, deletion of Tcf1 in Runx3 −/− CD8 + T EFF cells also improved activation of the cytotoxic program, particularly IFN-γ production and granzyme B expression, and enhanced expression of CD25 and Blimp-1, which may in turn help clonal expansion in response to acute infections. In fact, forced expression of CD25 in Runx3 −/− CD8 + T EFF cells did improve clonal expansion, albeit with little effect on increasing IFN-γ and granzyme B production (Q.S. and H.-H.X., unpublished data). These observations indicate that activation of the cytotoxic program and repression of the T FH program are not independent events, but are at least partly interconnected and coordinated by Runx3 and Tcf1. In naive CD8 + T cells, loss of Tcf1 alone causes upregulation of perforin, granzyme B and Blimp-1 without overt activation signals 8 . Thus, Tcf1 may function as a brake to restrain induction of the cytotoxic program in CD8 + T cells, and this may explain why Tcf1 is strongly downregulated in fully differentiated CD8 + effector T cells 39 . Thus, Runx3-mediated Tcf1 repression is critical for CD8 + T EFF cells to fully acquire cytotoxicity and prevent deviation to the T FH lineage.
During chronic infection, antigen-specific CD8 + T cells initially acquire effector functions, but gradually become less functional as a result of antigen persistence in the hosts 40 . A portion of the exhausted CD8 + T cells have been found to gain T FH -cell-like features, including expression of CXCR5, Bcl-6 and Tcf1, with CXCR5 + CD8 + T cells maintaining the pool of exhausted CD8 + T cells and contributing to viral curtailment more than their CXCR5 − CD8 + counterparts [26] [27] [28] . Thus, depending on the context of CD8 + T cell activation (for example, duration of antigen exposure and cytokine milieu), activation of the T FH program in CD8 + T cells may have beneficial effects. When Runx3 −/− CD8 + T cells were activated in response to protein immunization, the CXCR5 + CD8 + T EFF cells migrated into the B cell follicles and helped antibody production, and this B cell help function was not accompanied by germinal center formation, consistent with a current view of extrafollicular help to B cells [29] [30] [31] . Considering that the expression levels of key T FH factors such as Bcl6 remained lower in Runx3 −/− CD8 + T EFF cells than in wild-type CD4 + T FH cells, it is therefore not unexpected that the B cell help from the Runx3 −/− CXCR5 + CD8 + T EFF cells was not as potent as that from CD4 + T FH cells. Of note, exhausted CXCR5 + or Tcf1 hi CD8 + T cells induced by chronic infection express about 60-70% as much Runx3 transcript as CXCR5 − or Tcf1 lo CD8 + T cells 27, 41 . Runx3 may therefore represent A r t i c l e s a new target, and the resulting T FH plasticity in CD8 + effector T cells may benefit the control of chronic viral infections and/or tumor immunotherapy. Collectively, our results show that CD8 + T cell identity is under constant supervision both during development and after activation. The underlying regulatory circuits should provide useful tools to prevent unnecessary identity diversion and at the same time confer the desired plasticity.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. from 3-5 × 10 6 CD8 + T cells was immunoprecipitated with 5 µg of purified anti-CBFβ antibody 32 and was washed as described 23 . DNA segments from ChIP were end-repaired and ligated to indexed Illumina adaptors followed by low-cycle PCR. The resulting libraries were sequenced with the Illumina HiSeq-2000 platform.
The sequencing quality of ChIP-Seq libraries was assessed by FastQC. Bowtie2 v2.2.6 (ref. 49 ) was used to align the sequencing reads to the mm9 mouse genome. UCSC genes from the iGenome mouse mm9 assembly were used for gene annotation. MACS v1.4.2 (ref. 50) was used for peak calling with CBFβ ChIP-Seq in Cbfb −/− CD8 + T cells as a negative control. We used a stringent setting, that is, ≥ 4 fold enrichment, P < 10 −5 , and FDR < 5%, and identified 12,981 high-confidence CBFβ binding peaks in CD8 + T EFF cells.
To determine the overlap of CBFβ binding peaks with active enhancers, CBFβ binding peaks were compared with active enhancers defined above, and at least one base pair overlap was required to consider potential direct association of CBFβ with an active enhancer. To determine the overlap of CBFβ binding peaks with Runx3-binding peaks, the Runx3 ChIP-Seq data were retrieved from GSE50131 (ref. 22 ) and processed using the same protocol and stringent setting as above. At least one base pair overlap was required to consider a CBFβ peak and a Runx3 peak overlap with each other.
The profile of a histone mark flanking the CBFβ binding peaks in CD8 + T EFF cells was generated as follows. The CBFβ peaks were aligned by their summits, and the island-filtered reads of the histone mark were counted in a resolution of 100 bps and with smoothing window of 400 bp within ± 5 kb region flanking the summits. The read counts in each window were then normalized by the number of CBFβ peaks and by the window size, and expressed as reads per kb. The profile was further normalized by the total number of island-filtered reads in the histone mark library as reads per kilobase per million reads (RPKM). The CBFβ ChIP-Seq data are also under GEO accession number GSE81888.
De novo motif analysis. Among the 12,981 high-confidence CBFβ peaks in CD8 + T EFF cells, 5,186 were at the promoter region, and 1,758 overlapped with the putative enhancers (defined as H3K4Me1 hi H3K4Me3 neg/lo regions that are located within 5 kb of TSS). The top 3,000 most significant CBFβ peaks at the promoters as ordered by P value and all CBFβ peaks overlapping with the putative enhancers were used for motif analysis. The sequences of ± 200 bp flanking the peak summits, as identified by MACS, were used in MEME-ChIP for de novo motif discovery 51 .
Immunohistochemistry. Fresh spleens or LNs were snap-frozen in Tissue-Tek optimum cutting temperature (O.C.T.) compound (Sakura Finetek). Cryosections of 10 µm were cut, fixed in 4% of paraformaldehyde for 10 min followed by another 10-min incubation in pre-chilled acetone at −20 °C, and then washed three times with PBS for immunostaining. Following incubation in blocking buffer (CAS-Block, Invitrogen), the samples were incubated with fluorescence-labeled antibodies overnight at 4 °C. The primary antibodies used are anti-mouse CD8-Alexa Fluor 594 (53-6.7), anti-mouse B220-BV510 or B220-Alexa Fluor 647 (RA3-6B2 for both fluorochromes), and antimouse CD45.2-Alexa Fluor 488 (clone 104, all from BioLegend), each at 1:50 dilution. Confocal images of cryosections were acquired using a Zeiss LSM710 confocal fluorescence microscopy and were processed with Imaris software (Bitplane).
ChIP. Cbfb −/− or WT naïve CD8 + T cells were isolated by negative selection from uninfected mice. P14 CD8 + T EFF cells were sorted from CD45.1 + recipient mice on 5 dpi in adoptive transfer and LCMV-Arm infection experiments. The purified cells were cross-linked for 10 min with 1% formaldehyde in medium, were processed with a truChIP Chromatin Shearing Reagent Kit (Covaris) and sonicated for 5 min on Covaris S2 ultrasonicator. The sheared chromatin from 3-5 × 10 6 CD8 + cells was immunoprecipitated with 5 µg of purified anti-CBF-β antibody 32 or control rabbit IgG and was washed as described 23 . The immunoprecipitated DNA segments were used for quantification by PCR. For calculation of enriched binding by CBFβ, the signal at the genomic region of interest in each ChIP sample were first normalized to that at the Hprt promoter, and the enrichment by anti-CBFβ was then normalized to that by IgG in corresponding ChIP sample.
The primers used for ChIP-PCR are as follows: Prf1 TSS, 5′-agcactgcaccatgtcttca and 5′-atgcgctgtcaggaagagtt; Gzmb TSS, 5′-taaccacagcagaacccaca and 5′-tccaaaacactgatgctcca; Gzmb −22 kb enhancer, 5′-ccacctctagcagcacttcc and 5′-tgagcctctgtcatctgtgg; Prdm1 TSS, 5′-ctgccgcagacttctttacc and 5′-tttgcaaacagaggaagctg; Bcl6 TSS, 5′-ggcagcaacagcaataatca and 5′-ctgcggagcaatggtaaag; Tcf7 −37 kb region, 5′-tttctgctccccactcaaac and 5′-ttcctgaggtgacccatttc; Hprt TSS, 5′-tgagcgcaagttgaatctg and 5′-ggacgcagcaactgacatt.
Quantitative RT-PCR. P14 CD8 + T EFF cells were sorted from recipient mice in adoptive transfer and LCMV-Arm infection experiments. Total RNA was extracted, reverse-transcribed, and target gene transcripts were measured with quantitative PCR as described 7 . The primers used are as follows: Prdm1, 5′-cctgccaaccaggaacttct and 5′-gttgctttccgtttgtgtgaga; Prf1, 5′-gatgtgaacccta ggccaga and 5′-ggtttttgtaccaggcgaaa; Fasl, 5′-gcagaaggaactggcagaac and 5′-ttaa atgggccacactcctc; Tcf7, 5′-caatctgctcatgccctacc and 5′-cttgcttctggctgatgtcc; Bcl6, 5′-cctgagggaaggcaatatca and 5′-cggctgttcaggaactcttc; Actb, 5′-cggttccgat gccctgaggctctt and 5′-cgtcacacttcatgatggaattga.
Statistical analysis. For comparison between two experimental groups, Student's t test was used. For multi-group comparisons, one-way ANOVA was used to first determine whether any of the differences between the means are statistically significant, followed by 1) unpaired Student's t test to determine the statistical significance for a specific pair, 2) post hoc tests using Tukey's test and Bonferroni's test to more stringently determine the statistical significance of differences between all possible pairs 52 . In Figure 4d , the SMARTA CD4 + T cell recipient group was included as a positive control for the experimental system and was not included in the multi-group comparisons so as not to artificially reduce the statistical power of comparison among CD8 + T cell recipient groups. For comparison of numbers of wild-type, Runx3 −/− , Tcf7 −/− , Runx3 −/− Tcf7 −/− P14 CD8 + T EFF cells in response to various challenges, the values were log10 transformed for post hoc tests because the numbers of Runx3 −/− CD8 + T EFF cells were 1-2 logs lower than those of wild-type cells. Both unpaired t test and post hoc tests yielded consistent outcomes, although statistical power differed in some cases. In figures, the level of statistical significance was marked based on the most stringent Bonferroni's test, and that by unpaired t test and Tukey's test was provided in the "Source data-ANOVA/post-hoc test" file.
Data availability. High throughput sequencing data are deposited at the GEO with accession number GSE81888. Experimental protocols are described above or in cited references, and more details can be provided upon request.
Source data files for Figures 4 and 7, and Supplementary Figures 4 and 7 are available online.
